Bristol-Myers Squibb | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
AbbVie USD 1.46B 1.86B 2025-03
Abbott USD 50.83B 1.76B 2025-06
ALKERMES USD 1.62B 113M 2025-06
Amgen USD 7.43B 1.22B 2025-06
AstraZeneca USD 44.72B 3.68B 2025-06
Biogen USD 17.63B 655.3M 2025-06
Bristol-Myers Squibb USD 17.49B 100M 2025-06
Drreddys Laboratories INR 317.72B 12.38B 2024-12
Eli Lilly USD 18.27B 2.43B 2025-06
Gilead Sciences USD 19.67B 596M 2025-06
GlaxoSmithKline GBP 14.35B 197M 2025-06
J&J USD 78.11B 6.62B 2025-03
Medtronic USD 48.02B 1.36B 2025-04
Merck USD 49.06B 725M 2025-06
Novartis USD 42.05B 3.6B 2025-06
Novo Nordisk 168.07B 29.53B 2025-06
Perrigo USD 4.47B 108.3M 2025-06
Pfizer USD 88.7B 1.64B 2025-06
Prestige Brands USD 1.86B 20.58M 2025-06
Regeneron Pharmaceuticals USD 29.94B 551.3M 2025-06
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 70.28B 3.8B 2025-06
Sanofi 77.86B 4.86B 2024-12
United Therapeutics USD 7.17B 366.4M 2025-06
Zoetis USD 4.98B 322M 2025-06


Bristol-Myers Squibb Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.